These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6396475)

  • 21. The effect of rifampicin and dapsone on experimental Mycobacterium leprae infections: minimum inhibitory concentrations and bactericidal action.
    Holmes IB; Hilson GR
    J Med Microbiol; 1972 May; 5(2):251-61. PubMed ID: 4555734
    [No Abstract]   [Full Text] [Related]  

  • 22. Absence of enhancing effect of trimethoprim on the activity of a sulfonamide against Mycobacterium leprae.
    Pattyn SR; Verdoolaege-Van Loo G
    Int J Lepr Other Mycobact Dis; 1972; 40(3):320. PubMed ID: 4574275
    [No Abstract]   [Full Text] [Related]  

  • 23. In vitro and in vivo effects of N-methyl-3,5-dichloro-benzylamine hydrochloride on Mycobacterium leprae.
    Dhople AM; Strong LC; Meindl W; Schoenenberger H; Gardner GD
    Arzneimittelforschung; 1991 Mar; 41(3):253-6. PubMed ID: 1867663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Further studies of the action of antithyroid drugs on Mycobacterium leprae.
    Levy L; Anandan JA
    Proc Soc Exp Biol Med; 1978 Sep; 158(4):582-5. PubMed ID: 80802
    [No Abstract]   [Full Text] [Related]  

  • 25. In vitro and in vivo activities of ofloxacin against Mycobacterium leprae infection induced in mice.
    Saito H; Tomioka H; Nagashima K
    Int J Lepr Other Mycobact Dis; 1986 Dec; 54(4):560-2. PubMed ID: 3546546
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemotherapy of leprosy in multibacillary nude mice.
    Hastings RC; Chehl SK
    Indian J Lepr; 1991; 63(3-4):350-5. PubMed ID: 1804889
    [No Abstract]   [Full Text] [Related]  

  • 27. Activity of ansamycin against Mycobacterium leprae in mice.
    Hastings RC; Jacobson RR
    Lancet; 1983 Nov; 2(8358):1079-80. PubMed ID: 6138619
    [No Abstract]   [Full Text] [Related]  

  • 28. In vitro and in vivo experiments with the new inhibitor of mycobacterium leprae brodimoprim alone and in combination with dapsone.
    Seydel JK; Wempe EG; Rosenfeld M; Jagannathan R; Mahadevan PR; Dhople AM
    Arzneimittelforschung; 1990 Jan; 40(1):69-75. PubMed ID: 2187440
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activities of various quinolone antibiotics against Mycobacterium leprae in infected mice.
    Gelber RH; Iranmanesh A; Murray L; Siu P; Tsang M
    Antimicrob Agents Chemother; 1992 Nov; 36(11):2544-7. PubMed ID: 1336951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparative study of four rodent systems to monitor initial therapy of lepromatous leprosy: in search of a more sensitive system to assess bacterial viability.
    Gelber RH; Humphres RC; Fieldstell AH
    Acta Leprol; 1984; 2(2-4):319-25. PubMed ID: 6398591
    [No Abstract]   [Full Text] [Related]  

  • 31. Some characteristics of the action of dapsone on multiplication of Mycobacterium leprae in the mouse.
    Levy L; Peters JH
    Lepr Rev; 1977 Dec; 48(4):237-45. PubMed ID: 400808
    [No Abstract]   [Full Text] [Related]  

  • 32. Activity of the combination of isoniazid, protionamide and dapsone against Mycobacterium leprae and some other mycobacteria.
    Pattyn SR; Portaels F; Van Loo G; Van den Breen L
    Arzneimittelforschung; 1981; 31(12):2155-7. PubMed ID: 7037011
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The killing of Mycobacterium leprae in mice by various dietary concentrations of clofazimine and ethionamide.
    Gelber RH
    Lepr Rev; 1987 Dec; 58(4):407-11. PubMed ID: 3323753
    [No Abstract]   [Full Text] [Related]  

  • 34. In vitro synergistic activity between ofloxacin and ansamycins against Mycobacterium leprae.
    Dhople AM; Ibanez MA; Gardner GD
    Arzneimittelforschung; 1993 Mar; 43(3):384-6. PubMed ID: 8387790
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antimycobacterial activities of two newer ansamycins, R-76-1 and DL 473.
    Ji BH; Chen JK; Lu XZ; Wang SY; Ni GX; Hou YH; Zhou DH; Tang QK
    Int J Lepr Other Mycobact Dis; 1986 Dec; 54(4):563-77. PubMed ID: 3546547
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bactericidal activities of single or multiple doses of various combinations of new antileprosy drugs and/or rifampin against M. leprae in mice.
    Ji B; Perani EG; Petinon C; Grosset JH
    Int J Lepr Other Mycobact Dis; 1992 Dec; 60(4):556-61. PubMed ID: 1338596
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative in vitro and in vivo activity of fleroxacin and ofloxacin against various mycobacteria.
    Tomioka H; Sato K; Saito H
    Tubercle; 1991 Sep; 72(3):176-80. PubMed ID: 1771676
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-Mycobacterium leprae activity of several quinolones studied in the mouse.
    Pattyn SR
    Int J Lepr Other Mycobact Dis; 1991 Dec; 59(4):613-7. PubMed ID: 1666402
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Structure and anti-M. leprae activity relationships of new quinolones].
    Gidoh M
    Nihon Hansenbyo Gakkai Zasshi; 2009 Feb; 78(1):17-23. PubMed ID: 19227145
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The activity of rifabutin against Mycobacterium leprae.
    Yoder LJ; Jacobson RR; Hastings RC
    Lepr Rev; 1991 Sep; 62(3):280-7. PubMed ID: 1665534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.